Neuroepigenetics is a relatively new field of research that combines epigenetics and neuroscience to look at the influence of genetic and environmental factors on the development and function of the nervous system. This field focuses on the effects of various epigenetic processes, such as DNA methylation, histone modifications, and non-coding RNAs, on brain development, health, and behavior. It is an exciting area of research because it has the potential to revolutionize our understanding of the underlying mechanisms of neurological function and dysfunction. Epigenetic modifications can affect gene expression without changing the underlying DNA sequence. Studies have shown that these modifications can alter gene expression and can thus play an important role in the establishment, maintenance, and adaptive responses of the brain. For example, numerous changes in DNA methylation levels have been observed in various neurologic diseases, suggesting that epigenetic alterations of gene expression may contribute to the development of most common neurological disorders. Additionally, environmental exposures can lead to epigenetic changes in the brain, which may influence the outcome of neurological disorders. Studies in animal models have shown that epigenetic modifications can be induced by environmental factors and can even be passed down to succeeding generations. Such epigenetic modifications can disrupt normal neural functioning and alter behavior, providing evidence for an indirect heritable role for environment-induced epigenetic changes. Neuroepigenetics may also be involved in cognitive processes such as learning, memory, motor coordination, sleep, and other forms of brain plasticity. In conclusion, neuroepigenetics bridges the gap between the fields of neuroscience and epigenetics, providing a more complete understanding of the mechanisms of brain development, health, and behavior. Mechanistic studies of neuroepigenetics in humans and animal models will help us to develop innovative therapies and treatments that can restore normal functioning of the brain and improve quality of life.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States